Sexually transmitted infections cost the U.S. health care system $17 billion every year — and that number doesn’t even take into account the amount STDs cost to individuals in short-term and long-term consequences. We need more funding to prevent and treat these infections.
In this week’s sexual health roundup: scientists use engineered stem-cells to attack HIV; California tests a new pill that prevents HIV infection when taken daily but some question how expensive it is; the CDC releases alarming data on cancers caused by HPV in women; and South Carolina lawmakers take steps to increase HPV vaccination among middle school students.
A study out last week from the Centers for Disease Control and Prevention (CDC) found that half of teens who experienced an unintended pregnancy were not using birth control even though they did not want to get pregnant.
This week the CDC released a report that suggests that Americans are practicing fewer risky behaviors when it comes to HIV transmission.
A new study using a mathematical model suggests that public health efforts should focus on vaccinating either boys or girls against HPV but not both. The findings seem to counter a recent decision by the CDC which recommends vaccinating boys as well, but experts here say it is not time to start cancelling our son’s pediatrician appointments.
Today, a CDC advisory committee recommended that the HPV vaccine become a routine part of health care for 11-year-old boys as well as girls. Public and political reaction to this could serve as an interesting gauge of our double standard when it comes to adolescents and sex.
A recent study on LGBT healthcare in Wisconsin underscores the importance of passing a proposed law in California to improve the health of its LGBT residents. In doing so, California can teach Wisconsin a thing or two.
If the family planning infrastructure of our nation is obliterated by the current strains of extremism, we’ll see not only more unintended pregnancies and abortions, but also a big rise in STDs.
Hispanic women are 15 times more likely and Black women three more times likely than white women to be tested for Chlamydia. Dare I say racial differences in STI testing is due to doctors’ racial prejudices about the sexual behaviors of Women of Color?
New data suggest mixed progress and ongoing challenges in the United States when it comes to the three most commonly reported STDs: Chlamydia, Gonorrhea, and Syphilis.